BLENREP vs LENALIDOMIDE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 16, 2026·How we rate

Possible drug interaction. BLENREP and LENALIDOMIDE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	BLENREP	LENALIDOMIDE
Rating	70/100	70/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	BELANTAMAB MAFODOTIN-BLMF	LENALIDOMIDE
Manufacturer	Glaxosmithkline	Cipla
Dosage forms	Injectable	Capsule
Drug class	—	Thalidomide Analog
Boxed warning	Boxed warning	Boxed warning
Half-life	—	about 3 hours in healthy subjects, and 3 to 5 hours in patients with multiple myeloma, MDS, or mantle cell lymphoma
Treats	Multiple Myeloma	Multiple Myeloma, Myelodysplastic Syndromes, Mantle-Cell Lymphoma

blenrep lenalidomide

Rating

70/100

Pharmacy pays

—

Type

Active ingredient

BELANTAMAB MAFODOTIN-BLMF

LENALIDOMIDE

Manufacturer

Glaxosmithkline

Cipla

Dosage forms

Injectable

Capsule

Drug class

—

Thalidomide Analog

Boxed warning

Half-life

—

about 3 hours in healthy subjects, and 3 to 5 hours in patients with multiple myeloma, MDS, or mantle cell lymphoma

Treats

Multiple Myeloma

Multiple Myeloma, Myelodysplastic Syndromes, Mantle-Cell Lymphoma

Frequently asked questions

Which is better-rated, Blenrep or Lenalidomide?

Blenrep and Lenalidomide are tied at 3.5 out of 5 by our independent rating.

What is the difference between Blenrep and Lenalidomide?

Blenrep contains Belantamab Mafodotin-Blmf, while Lenalidomide contains Lenalidomide — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.